Stock Market

Competition among electric vehicle manufacturers is never-ending, not only in the U.S. but worldwide. Some data points might lead investors to believe that China-based EV maker Nio (NYSE:NIO) is thriving amid the fierce competition. However, prospective NIO stock buyers need to be careful now as the recent news it’s all positive for Nio. Ultimately, there’s a lesson to be
0 Comments
Palantir Technologies (NASDAQ:PLTR), recognized for big data services and government contracts, attracted attention with blockchain and AI advancements. However, despite high-profile deals, PLTR stock’s financial performance disappointed, leading some to see it as a “glorified consultant” rather than a tech innovator. Intense competition from more profitable consulting firms presents a challenge. Despite the easing of
0 Comments
It’s been a long way down for former market darling Block (NYSE:SQ). Block stock soared during the pandemic as merchants and consumers were forced to switch to digital payments because of lockdowns. In just 18 months shares soared nearly 600%, but it was short-lived. Investors saw the fintech stock lose almost 90% of its value
0 Comments
Initially concentrated on defense and intelligence, Palantir Technologies (NYSE:PLTR) has broadened its clientele to the healthcare, energy, and finance sectors. Noteworthy profitability and advancements in AI analytics make PLTR stock an appealing choice for investors. Despite the cooling of ‘AI mania,’ Palantir Technologies continues to hold firm, with shares not far below their 52-week highs.
0 Comments
In 2024, UBS expects disinflation and rising unemployment to impact economic output, prompting the Federal Open Market Committee to implement proactive rate cuts. The FEderal Open Market Committee designed the initial cut to prevent the nominal funds rate from becoming overly restrictive amid falling inflation, with subsequent cuts later in the year to counteract economic
0 Comments
InvestorPlace published an article last December about the seven hottest biotech stocks to own in 2023 and beyond. One of the seven was the SPDR S&P Biotech ETF (NYSEARCA:XBI). XBI tracks the performance of the S&P Biotechnology Select Industry Index which represents the biotechnology sub-sector of the S&P Total Market Index. XBI currently has 133
0 Comments
Alphabet (NASDAQ:GOOGL,NASDAQ:GOOG) stock continues to be affected by the U.S. Department of Justice civil suit filed back in January, alleging that the company engaged in monopolistic and anti-competitive actions in order to maintain its dominant position in search and digital advertising markets. The trial, which started in September, is still unfolding. However, in recent days,
0 Comments